60.56
price down icon0.35%   -0.21
after-market アフターアワーズ: 60.65 0.09 +0.15%
loading
前日終値:
$60.77
開ける:
$60.77
24時間の取引高:
628.81K
Relative Volume:
0.48
時価総額:
$5.86B
収益:
$7.50M
当期純損益:
$-383.17M
株価収益率:
-12.87
EPS:
-4.7048
ネットキャッシュフロー:
$-307.84M
1週間 パフォーマンス:
-2.89%
1か月 パフォーマンス:
-7.43%
6か月 パフォーマンス:
+35.21%
1年 パフォーマンス:
+55.92%
1日の値動き範囲:
Value
$60.00
$61.05
1週間の範囲:
Value
$59.27
$64.93
52週間の値動き範囲:
Value
$35.60
$72.66

Xenon Pharmaceuticals Inc Stock (XENE) Company Profile

Name
名前
Xenon Pharmaceuticals Inc
Name
セクター
Healthcare (1033)
Name
電話
(604) 484-3300
Name
住所
200 - 3650 GILMORE WAY, BURNABY
Name
職員
370
Name
Twitter
Name
次回の収益日
2026-08-10
Name
最新のSEC提出書
Name
XENE's Discussions on Twitter

Compare XENE vs VRTX, REGN, ARGX, MRNA, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
XENE icon
XENE
Xenon Pharmaceuticals Inc
60.56 5.78B 7.50M -383.17M -307.84M -4.7048
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
547.59 136.93B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
828.50 85.11B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
1,011.11 64.95B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
138.89 53.23B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
211.58 45.38B 742.00K -1.37B -1.07B -7.0731

Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-02-24 開始されました Wolfe Research Outperform
2025-09-03 再開されました Wells Fargo Overweight
2025-05-07 開始されました Chardan Capital Markets Buy
2025-02-11 開始されました Deutsche Bank Buy
2024-10-10 再開されました Raymond James Outperform
2024-10-01 開始されました H.C. Wainwright Buy
2024-01-04 開始されました Citigroup Buy
2023-12-08 開始されました Robert W. Baird Outperform
2023-10-24 再開されました Cantor Fitzgerald Overweight
2023-04-25 開始されました Cantor Fitzgerald Overweight
2022-12-14 開始されました Goldman Buy
2022-12-12 開始されました Cowen Outperform
2022-11-28 開始されました Wells Fargo Overweight
2022-10-19 開始されました Raymond James Outperform
2022-08-29 開始されました BofA Securities Buy
2022-07-21 開始されました JP Morgan Overweight
2021-10-28 開始されました RBC Capital Mkts Outperform
2020-10-02 開始されました SVB Leerink Outperform
2020-07-21 開始されました Needham Buy
2020-06-01 再開されました Jefferies Buy
2020-03-25 開始されました Wedbush Outperform
2020-01-08 開始されました William Blair Outperform
2019-09-20 開始されました Guggenheim Buy
2018-08-08 繰り返されました Stifel Buy
2017-03-13 開始されました Jefferies Buy
2016-10-21 開始されました Stifel Buy
2016-09-26 開始されました Guggenheim Buy
2016-04-14 繰り返されました Jefferies Buy
2015-10-30 再開されました Jefferies Buy
2014-12-02 開始されました Canaccord Genuity Buy
すべてを表示

Xenon Pharmaceuticals Inc (XENE) 最新ニュース

pulisher
Aug 21, 2026

Bank of America Corp DE Increases Stock Holdings in Xenon Pharmaceuticals Inc. $XENE - MarketBeat

Aug 21, 2026
pulisher
Aug 20, 2026

Xenon (XENE) Today: Ends Down by 4.16% at $59.73 for the Current Session; Technical Setup: Support at $56.74 and Resistance at $62.72 Frame the Range under the Current SnapshotMcClellan Oscillator - Vinanet

Aug 20, 2026
pulisher
Aug 20, 2026

Xenon Pharmaceuticals (XENE) Q2 2026 Earnings Call Transcript - AOL.com

Aug 20, 2026
pulisher
Aug 19, 2026

Should Xenon’s Wider Q2 Losses to Fund Neurology Pipeline Require Action From Xenon (XENE) Investors? - simplywall.st

Aug 19, 2026
pulisher
Aug 18, 2026

Xenon Pharmaceuticals (XENE) Holds Steady at $62.36 as Shares Consolidate Below Key ResistanceIV Rank - vinanet.vn

Aug 18, 2026
pulisher
Aug 18, 2026

TimesSquare Capital Management LLC Purchases Shares of 451,593 Xenon Pharmaceuticals Inc. $XENE - MarketBeat

Aug 18, 2026
pulisher
Aug 17, 2026

Xenon Pharmaceuticals (XENE) Could Be 23% Undervalued As Epilepsy Growth Narrative Holds - Sahm

Aug 17, 2026
pulisher
Aug 16, 2026

Xenon Pharmaceuticals (XENE) Pulls Back 2.93% as Shares Approach Critical SupportCall Wall - vinanet.vn

Aug 16, 2026
pulisher
Aug 15, 2026

Xenon Pharmaceuticals Independent Director Steven Gannon Sells 84% Of Holding - simplywall.st

Aug 15, 2026
pulisher
Aug 15, 2026

Walleye Capital LLC Buys New Position in Xenon Pharmaceuticals Inc. $XENE - MarketBeat

Aug 15, 2026
pulisher
Aug 14, 2026

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Rating of "Buy" by Brokerages - MarketBeat

Aug 14, 2026
pulisher
Aug 14, 2026

Xenon Pharmaceuticals (XENE) Insider Sells 10,000 Shares; Direct - GuruFocus

Aug 14, 2026
pulisher
Aug 13, 2026

(XENE) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Aug 13, 2026
pulisher
Aug 13, 2026

Xenon Pharmaceuticals (NASDAQ:XENE) Director Sells 10,000 Shares of Stock - MarketBeat

Aug 13, 2026
pulisher
Aug 13, 2026

Xenon Pharmaceuticals (XENE) director sells 10,000 common shares at $64 - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

Xenon Pharmaceuticals Insider Sold Shares Worth $640,550, According to a Recent SEC Filing - marketscreener.com

Aug 13, 2026
pulisher
Aug 13, 2026

Xenon Pharmaceuticals Director Sold Shares Worth Over $640K - TradingView

Aug 13, 2026
pulisher
Aug 13, 2026

Seller for XENE (NASDAQ: XENE) plans 10,000-share common stock sale - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

Wellington group discloses 1.47% Xenon Pharmaceuticals (XENE) stake for advisory clients - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

Xenon Pharmaceuticals (NASDAQ:XENE) Presents High-Quality Technical Breakout Setup - ChartMill

Aug 13, 2026
pulisher
Aug 11, 2026

Xenon Pharmaceuticals: Strong Buy On Azetukalner NDA And MDD Expansion Opportunity (XENE) - Seeking Alpha

Aug 11, 2026
pulisher
Aug 11, 2026

HC Wainwright Issues Positive Outlook for XENE Earnings - MarketBeat

Aug 11, 2026
pulisher
Aug 11, 2026

Xenon Pharmaceuticals Inc. (XENE): Analyst Consensus Highlights 26.65% Potential Upside - DirectorsTalk Interviews

Aug 11, 2026
pulisher
Aug 10, 2026

H.C. Wainwright reiterates Xenon Pharmaceuticals stock rating at buy - Investing.com

Aug 10, 2026
pulisher
Aug 10, 2026

H.C. Wainwright reiterates Xenon Pharmaceuticals stock rating at buy By Investing.com - Investing.com Canada

Aug 10, 2026
pulisher
Aug 10, 2026

Brokers Issue Forecasts for XENE Q1 Earnings - MarketBeat

Aug 10, 2026
pulisher
Aug 09, 2026

Quantinno Capital Management LP Purchases 30,816 Shares of Xenon Pharmaceuticals Inc. $XENE - MarketBeat

Aug 09, 2026
pulisher
Aug 08, 2026

FDA Pre-NDA Progress On Azetukalner Could Be A Game Changer For Xenon Pharmaceuticals (XENE) - webull.com

Aug 08, 2026
pulisher
Aug 08, 2026

Xenon Pharmaceuticals Stock Price Forecast. Should You Buy XENE? - StockInvest.us

Aug 08, 2026
pulisher
Aug 07, 2026

A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $81 to $90 - Moomoo

Aug 07, 2026
pulisher
Aug 07, 2026

H.C. Wainwright Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $74 - Moomoo

Aug 07, 2026
pulisher
Aug 07, 2026

XENE Maintained by RBC Capital -- Price Target Lowered to $81.00 - GuruFocus

Aug 07, 2026
pulisher
Aug 07, 2026

Xenon Pharmaceuticals Q2 Earnings Call Highlights - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

Wedbush Adjusts PTon Xenon Pharmaceuticals to $71 From $63, Maintains Outperform Rating - Moomoo

Aug 07, 2026
pulisher
Aug 07, 2026

Xenon Pharmaceuticals' Azetukalner NDA Filing Remains on Track After FDA Meeting, RBC Says - marketscreener.com

Aug 07, 2026
pulisher
Aug 07, 2026

Xenon Pharmaceuticals Inc. Stock 12‑Month Price Target Raised to $81.21, Implies 26% Upside - TradingView

Aug 07, 2026
pulisher
Aug 07, 2026

FMR LLC (XENE) discloses 9.96M-share, 10.3% holding in Xenon Pharmaceuticals - Stock Titan

Aug 07, 2026
pulisher
Aug 07, 2026

XENE's Q2 Loss Narrower Than Expected, Sales Nil, Pipeline in Focus - Yahoo Finance

Aug 07, 2026
pulisher
Aug 07, 2026

RBC Adjusts Xenon Pharmaceuticals PT to $81 From $82, Maintains Outperform Speculative Risk Rating - marketscreener.com

Aug 07, 2026
pulisher
Aug 07, 2026

Xenon Pharmaceuticals Q2 2026 Earnings Call Transcript - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

California State Teachers Retirement System Buys 36,183 Shares of Xenon Pharmaceuticals Inc. $XENE - marketbeat.com

Aug 07, 2026
pulisher
Aug 07, 2026

Xenon Pharmaceuticals (NASDAQ:XENE) Announces Quarterly Earnings Results - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

Xenon Pharmaceuticals Inc (XENE) (Q2 2026) Earnings Call Highlights: Advancing Azetukalner ... - Yahoo! Finance Canada

Aug 07, 2026
pulisher
Aug 07, 2026

Xenon Pharmaceuticals Inc (XENE) (Q2 2026) Earnings Call Highlig - GuruFocus

Aug 07, 2026
pulisher
Aug 06, 2026

XENON PHARMACEUTICALS INC. : WEDBUSH RAISES TARGET PRICE TO $71 FROM $63 - Bitget

Aug 06, 2026
pulisher
Aug 06, 2026

XENE Advances Pipeline with NDA Submission Plans Amid High Price-to-Sales Valuation - GuruFocus

Aug 06, 2026
pulisher
Aug 06, 2026

Xenon Pharmaceuticals Q2 Loss Widens - marketscreener.com

Aug 06, 2026
pulisher
Aug 06, 2026

Earnings Flash (XENE) Xenon Posts Q2 Loss Per Share $1.11, vs. FactSet Est of $1.14 Loss - marketscreener.com

Aug 06, 2026
pulisher
Aug 06, 2026

Xenon Pharmaceuticals Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

Xenon Pharmaceuticals Inc. Q2 2026: Revenue $0 EPS $(1.11) — 10-Q Summary - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

Xenon Pharmaceuticals Inc. R (XP0.F) Q2 FY2026 earnings call transcript - Yahoo Finance

Aug 06, 2026

Xenon Pharmaceuticals Inc (XENE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$123.98
price up icon 0.00%
$61.33
price up icon 0.03%
$112.82
price down icon 3.22%
$236.01
price down icon 0.09%
ONC ONC
$371.98
price down icon 0.66%
$211.58
price up icon 1.01%
大文字化:     |  ボリューム (24 時間):